![]() ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | ||
Founding Date | Founding Date 2018 | Founding Date 2003 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Athens, US HQ Athens, US |
Employees | Employees 2318% decrease | Employees 274% increase |
Funding | ||
Latest funding round | Latest funding round $ 50m (over 5 years ago) | Latest funding round $ 4.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 26.9m |

ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company